METOPIRONE 250mg capsule me medication leaflet

V04CD01 metirapone • Various | Other diagnostic agents | Tests for pituitary function

Metyrapone is a cortisol synthesis inhibitor used for the diagnosis of adrenal insufficiency and the treatment of Cushing's syndrome. It works by inhibiting the enzyme 11-beta-hydroxylase, reducing cortisol production.

The medication is taken orally, usually in divided doses, with the dose adjusted based on the patient's response and hormone levels. Common side effects include nausea, vomiting, abdominal pain, and dizziness.

Metyrapone is contraindicated in patients with hypersensitivity to the active substance or severe hepatic impairment. Its use also requires careful monitoring of adrenal function and blood pressure.

This medication is an important option for diagnosing and managing adrenal disorders, helping to improve patients' quality of life.

General data about METOPIRONE 250mg

Substance: metirapone

Date of last drug list: 01-06-2025

Commercial code: W66831001

Concentration: 250mg

Pharmaceutical form: capsule me

Quantity: 50

Product type: generic

Price: 1275.87 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: DELPHARM LILLE S.A.S. - FRANTA

Holder: HRA PHARMA RARE DISEASES - FRANTA

Number: 15076/2023/01

Shelf life: Dupa ambalare pentru comercializare - 3 years; After first opening the bottle. - 2 months